Filing Details
- Accession Number:
- 0001209191-18-002807
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2018-01-08 20:16:33
- Reporting Period:
- 2017-12-04
- Accepted Time:
- 2018-01-08 20:16:33
- Original Submission Date:
- 2018-01-05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1437786 | Immune Design Corp. | IMDZ | Pharmaceutical Preparations (2834) | 262007174 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1686295 | Sergey Yurasov | C/O Immune Design Corp. 1616 Eastlake Ave. E., Suite 310 Seattle WA 98102 | Sr. Vp, Clinic. Devel. & Cmo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-01-05 | 675 | $4.17 | 27,325 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The shares were sold pursuant to a Rule 10b5-1 trading plan that was included in the Reporting Person's restricted stock unit agreement, dated January 4, 2017, in order to satisfy a tax liability incurred upon the vesting of restricted stock units on January 4, 2018.
- On January 5, 2018, the reporting person filed a Form 4 that inadvertently reported (i) an incorrect transaction date and (ii) omitted an applicable footnote referring to the fact that the shares were sold pursuant to a current 10b5-1 trading plan.
Billionaire Hedge Funds
